Viking Global Investors LP is > 10% Shareholder of Editas Medicine, Inc.. Currently has a direct ownership of 266,782 shares of EDIT, which is worth approximately $349,484. The most recent transaction as insider was on Feb 08, 2015, when has been sold 1,020,407 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 267K
0% 3M change
0% 12M change
Total Value Held $349,484

VIKING GLOBAL INVESTORS LP Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 08 2015
BUY
Open market or private purchase
-
1,020,407 Added 79.27%
266,782 Common Stock
Feb 08 2015
BUY
Conversion of derivative security
-
1,709,401 Added 50.0%
1,709,401 Common Stock

Also insider at

W
Wayfair Inc. Consumer Cyclical
FDC
FIRST DATA CORP
ABUS
Arbutus Biopharma Corp Healthcare
MYOV
Myovant Sciences Ltd. Healthcare
SIOX
Sio Gene Therapies Inc. Healthcare
UROV
Urovant Sciences Ltd.
BBIO
BridgeBio Pharma, Inc. Healthcare
ADPT
Adaptive Biotechnologies Corp Healthcare
DNA
Ginkgo Bioworks Holdings, Inc. Healthcare
ZNTL
Zentalis Pharmaceuticals, Inc. Healthcare
INBX
Inhibrx, Inc. Healthcare
FDMT
4D Molecular Therapeutics, Inc. Healthcare
RLYB
Rallybio Corp Healthcare
FIGS
FIGS, Inc. Consumer Cyclical
PRCT
PROCEPT BioRobotics Corp Healthcare
APG
APi Group Corp Industrials
AMLX
Amylyx Pharmaceuticals, Inc. Healthcare
RYZB
RayzeBio, Inc.
FLAC
Frazier Lifesciences Acquisition Corp Financial Services
ROIV
Roivant Sciences Ltd. Healthcare
VGI

Viking Global Investors LP

> 10% Shareholder

Track Institutional and Insider Activities on EDIT

Follow Editas Medicine, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells EDIT shares.

Notify only if

Insider Trading

Get notified when an Editas Medicine, Inc. insider buys or sells EDIT shares.

Notify only if

News

Receive news related to Editas Medicine, Inc.

Track Activities on EDIT